Summation Bio

Somerville, United States

Summation Bio is a gene therapy company that develops a novel non-viral gene transfer technology.

$24.5M raised

Apr 2022

Series A

Biotechnology Genetics Therapeutics

Founder Contacts

30,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Summation Bio

How much funding has Summation Bio raised?

Summation Bio has raised $24.5M in total funding. The most recent round was Series A. The last funding was announced in April 2022.

Where is Summation Bio headquartered?

Summation Bio is headquartered in Somerville, United States.

What does Summation Bio do?

Summation Bio is a gene therapy company that develops a novel non-viral gene transfer technology.

What stage is Summation Bio at?

Summation Bio is at the Series A stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 4, 2022.

MLA

"Summation Bio — Funding & Investors." VCBacked, April 4, 2022, https://www.vcbacked.co/company/summation-bio. Accessed July 2, 2026.

APA

VCBacked. (2022). Summation Bio — Funding & Investors. Retrieved July 2, 2026, from https://www.vcbacked.co/company/summation-bio

Wikipedia (cite web)

{{cite web |title=Summation Bio — Funding & Investors |url=https://www.vcbacked.co/company/summation-bio |website=VCBacked |access-date=July 2, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 4, 2022.

Similar Companies in Biotechnology

View all

Rapport Therapeutics

Boston$250.0M

Renaissance BioScience

Vancouver$599K

Allterum Therapeutics

Advanced Microbiome Interventions

Amsterdam$300K